This company listing is no longer active
De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Clover Biopharmaceuticals Beheer
Beheer criteriumcontroles 0/4
Clover Biopharmaceuticals' CEO is Joshua G. Liang, appointed in Dec 2020, has a tenure of 2.75 years. total yearly compensation is CN¥30.29M, comprised of 26.9% salary and 73.1% bonuses, including company stock and options. directly owns 1.48% of the company’s shares, worth HK$18.53M. The average tenure of the management team and the board of directors is 1.7 years and 2 years respectively.
Belangrijke informatie
Joshua G. Liang
Algemeen directeur
CN¥30.3m
Totale compensatie
| Percentage CEO-salaris | 26.9% |
| Dienstverband CEO | 2.8yrs |
| Eigendom CEO | 1.5% |
| Management gemiddelde ambtstermijn | 1.7yrs |
| Gemiddelde ambtstermijn bestuur | 2yrs |
Recente managementupdates
Recent updates
Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2023 | n/a | n/a | -CN¥665m |
| Mar 31 2023 | n/a | n/a | -CN¥2b |
| Dec 31 2022 | CN¥30m | CN¥8m | -CN¥2b |
| Sep 30 2022 | n/a | n/a | -CN¥4b |
| Jun 30 2022 | n/a | n/a | -CN¥6b |
| Mar 31 2022 | n/a | n/a | -CN¥6b |
| Dec 31 2021 | CN¥15m | CN¥8m | -CN¥6b |
| Dec 31 2020 | CN¥4m | CN¥4m | -CN¥913m |
Compensatie versus markt: Joshua G.'s total compensation ($USD4.14M) is above average for companies of similar size in the Hong Kong market ($USD335.32K).
Compensatie versus inkomsten: Joshua G.'s compensation has increased whilst the company is unprofitable.
CEO
Joshua G. Liang (30 yo)
2.8yrs
Tenure
CN¥30,285,000
Compensatie
Mr. Joshua G. Liang is Executive Director and Chief Executive Officer at Clover Biopharmaceuticals, Ltd. since December 25, 2020. Mr. Liang is primarily responsible for leading the management and operation...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Founder | 4.9yrs | CN¥10.45m | 16.19% CN¥ 203.2m | |
| CEO & Executive Director | 2.8yrs | CN¥30.29m | 1.48% CN¥ 18.5m | |
| Chief Financial Officer | 1.3yrs | geen gegevens | geen gegevens | |
| Chief Technology Officer | less than a year | geen gegevens | geen gegevens | |
| Director of Investor Relations | less than a year | geen gegevens | geen gegevens | |
| Executive Director of Corporate Communications | less than a year | geen gegevens | geen gegevens | |
| Chief People Officer | 1.8yrs | geen gegevens | geen gegevens | |
| Chief Medical Officer of Vaccine | 2.6yrs | geen gegevens | geen gegevens | |
| Chief Technical Operation Officer | no data | geen gegevens | geen gegevens | |
| Senior Vice President of Corporate Strategy & Business Development | 1.8yrs | geen gegevens | geen gegevens | |
| Senior Vice President of Head of Regulatory Affairs | 1.8yrs | geen gegevens | geen gegevens | |
| President of Global Research & Development | 1.6yrs | geen gegevens | geen gegevens |
1.7yrs
Gemiddelde duur
53yo
Gemiddelde leeftijd
Ervaren management: 2197's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Founder | 4.9yrs | CN¥10.45m | 16.19% CN¥ 203.2m | |
| CEO & Executive Director | 2.8yrs | CN¥30.29m | 1.48% CN¥ 18.5m | |
| Independent Non-Executive Director | 2yrs | CN¥2.21m | 0.011% CN¥ 143.2k | |
| Non-Executive Director | 1.3yrs | CN¥1.30m | 0.039% CN¥ 484.8k | |
| Non-Executive Director | 2.5yrs | CN¥2.20m | 2.18% CN¥ 27.3m | |
| Non-Executive Director | 1.3yrs | CN¥527.00k | 0.0067% CN¥ 84.6k | |
| Independent Non-Executive Director | 2yrs | CN¥2.32m | 0.011% CN¥ 143.2k | |
| Independent Non-executive Director | 2yrs | CN¥2.29m | 0.011% CN¥ 143.2k | |
| Independent Non-Executive Director | 2yrs | CN¥2.21m | 0.011% CN¥ 143.2k |
2.0yrs
Gemiddelde duur
61yo
Gemiddelde leeftijd
Ervaren bestuur: 2197's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.